Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 11, Issue 11, pp. 2535-2540
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 17, 2012
- Revision received July 13, 2012
- Accepted July 26, 2012
- Published first August 14, 2012.
Article Versions
- Previous version (August 14, 2012 - 14:20).
- Previous version (November 6, 2012 - 14:33).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Paul K. Paik1,4,
- Anna M. Varghese1,4,
- Camelia S. Sima2,
- Andre L. Moreira3,
- Marc Ladanyi3,
- Mark G. Kris1,4, and
- Natasha Rekhtman3
- Authors' Affiliations: 1Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, and 2Department of Epidemiology and Biostatistics, and 3Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; 4Department of Medicine, Weill Cornell Medical College, New York, New York
- Corresponding Author:
Paul K. Paik, Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, New York, NY 10065. Phone: 646-888-4202; Fax: 646-888-4263; E-mail: paikp{at}mskcc.org
November 2012
Volume 11, Issue 11
Volume 11, Issue 11
Response to Erlotinib in Patients with EGFR Mutant Advanced Non–Small Cell Lung Cancers with a Squamous or Squamous-like Component
Jump to section
Advertisement